11/15/2024 9:31 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2024 3:15 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2024 1:58 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/05/2024 3:11 PM | Vertex Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/17/2024 3:12 PM | SACHS BRUCE I (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 3:12 PM | Biller Jonathan (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2024 9:04 AM | Biller Jonathan (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/30/2024 3:47 PM | Bhatia Sangeeta N. (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024 3:23 PM | LEIDEN JEFFREY M (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024 3:08 PM | Bhatia Sangeeta N. (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 10:47 AM | Bhatia Sangeeta N. (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024 8:52 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024 3:17 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 2:34 PM | SACHS BRUCE I (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024 2:25 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024 3:06 PM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2024 3:05 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2024 11:27 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024 12:16 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 9:27 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024 9:23 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2024 3:09 PM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 3:11 PM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 8:54 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024 8:56 AM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024 3:11 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:09 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 12:56 PM | Vertex Pharmaceuticals (Subject) WAGNER CHARLES F JR (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 12:38 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024 9:50 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024 10:48 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024 3:08 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 9:05 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024 9:51 AM | Vertex Pharmaceuticals (Subject) WAGNER CHARLES F JR (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024 12:13 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024 3:21 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 12:45 PM | SACHS BRUCE I (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024 2:32 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024 7:36 AM | Vertex Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/20/2024 7:25 AM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/15/2024 11:20 AM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
I've got news for you… (Ad) Today, I’m doing something I thought I’d never do…
Especially since I’m not normally a “swing for the fences” type of trader.
But I’ve been quietly testing a new type of trade for a while now…
And the returns are too good not to share with you.
Take a look…
I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week watch this FREE briefing with me and expert trader Graham Lindman |
05/15/2024 10:41 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024 10:50 AM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2024 7:01 AM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/08/2024 7:54 AM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/03/2024 3:05 PM | Bhatia Sangeeta N. (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 9:07 AM | Bhatia Sangeeta N. (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/22/2024 3:15 PM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-T | |
04/16/2024 3:56 PM | Arjuna Capital (Filed by) Vertex Pharmaceuticals (Subject)
| Form PX14A6G | |
04/11/2024 3:08 PM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-C | |
04/11/2024 6:13 AM | Vertex Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2024 6:17 AM | Vertex Pharmaceuticals (Subject)
| Form SC TO-C | |
04/10/2024 4:22 PM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-C | |
04/10/2024 11:14 AM | Capital World Investors (Filed by) Vertex Pharmaceuticals (Subject)
| Form SC 13G/A | |
04/04/2024 3:05 PM | Vertex Pharmaceuticals (Filer)
| Form ARS | |
02/27/2024 3:44 PM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 3:37 PM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 3:24 PM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 12:19 PM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 10:25 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 10:10 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 9:44 AM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 9:52 AM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 9:26 AM | Sanna Bastiano (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024 3:28 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:16 PM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:43 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:49 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:38 PM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:26 PM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:29 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 10:38 AM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 9:44 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 9:52 AM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 9:16 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 8:50 AM | Sanna Bastiano (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 8:43 AM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 10:03 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 10:29 AM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 9:57 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 9:32 AM | Sanna Bastiano (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 9:22 AM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 9:22 AM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024 10:19 AM | LEIDEN JEFFREY M (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 4:11 PM | Sanna Bastiano (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 4:34 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 4:23 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 12:42 PM | Biller Jonathan (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 12:24 PM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 11:44 AM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 10:32 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
This Bull Market Indicator called NVDA at $116 (Ad) Every now and again we find an investment idea so incredible we can’t help but share.
And today is one of those rare days…
Except, today we won't be giving you insight on any one particular stock…
But rather, insight on a revolutionary new stock picking indicator…
In fact, within the last year, this indicator has become famous for a multitude of reasons…
But one of the biggest was because of the buy signal it issued on October 18th, 2022.
In fact, on that very day, it said to buy NVDA at $116.37…
Anyone who did would be sitting on a tremendously large return today…
But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run… All you have to do is follow this link here |
02/12/2024 9:32 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 8:52 AM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024 5:19 PM | Capital World Investors (Filed by) Vertex Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024 9:05 AM | FMR LLC (Filed by) Vertex Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024 3:38 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 3:40 PM | LEIDEN JEFFREY M (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 3:43 PM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 3:45 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 3:47 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |